Cleared Traditional

TONSIL SPONGE, GAUZE DISSECTOR, CYLINDRICAL SPONGES (K940903) - FDA 510(k) Clearance

Class I Ear, Nose, Throat device.

K940903 · Medical Insights, Inc. · Ear, Nose, Throat device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1994
Decision
49d
Days
Class 1
Risk

K940903 is an FDA 510(k) clearance for the TONSIL SPONGE, GAUZE DISSECTOR, CYLINDRICAL SPONGES. Classified as Dissector, Tonsil (product code KBM), Class I - General Controls.

Submitted by Medical Insights, Inc. (Mystic, US). The FDA issued a Cleared decision on April 14, 1994 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.4420 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medical Insights, Inc. devices

Submission Details

510(k) Number K940903 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 24, 1994
Decision Date April 14, 1994
Days to Decision 49 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 89d · This submission: 49d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KBM Dissector, Tonsil
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 874.4420
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.